| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2405361 | Vaccine | 2009 | 8 Pages |
Abstract
In adult recipients, Tdap3v was comparable to an approved Tdap vaccine in providing seroprotection against diphtheria and tetanus, and produced immune responses to pertussis antigens consistent with protection against disease. The overall safety profile of Tdap3v was generally comparable to that of Tdap5v [NCT #106316].
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mark Blatter, Leonard R. Friedland, Wayde M. Weston, Ping Li, Barbara Howe,